Milestones
- Walking via brain-spine link (Nature)May 2023Complete.
- FDA authorizes ARC-EXDec 2024Complete.
- ARC-EX US launch2025Complete.
- ARC-IM main-trial developmentNowCurrent milestone.
Most important updates
- 17 Oct 2025
- 19 Dec 2024
- 20 May 2024
- 24 May 2023
- 31 Oct 2018
Upcoming
- Nov 2026Empower BP pivotal study of ARC-IM for blood pressure (NCT07147296) primary completion, per trial registryin about 3 weeks (next)
Current obstacles
- Results vary a lotBenefit depends on how many spinal connections survive and on hard rehab, so results differ widely.
Physics limits
- It needs surviving nerve fibresStimulation amplifies connections that cross the injury. Where no fibres survive, the brain's commands have no path through, however the cord is stimulated.
- Skin pads can't aim preciselyCurrent from skin electrodes spreads widely through tissue before reaching the cord, so it can't target individual nerve roots as finely as an implant.
- Without a brain link, it can't know intentStimulation alone doesn't know when the person wants to move; precise, natural timing needs a decoder, which adds brain surgery.
How it works

Some wiring survives
Most spinal injuries leave some nerve fibres intact, but the brain's signals arriving through them are too weak to move muscles.
Pulses raise the cord's readiness
Timed pulses to the cord below the injury, from skin pads (ARC-EX) or an implant (ARC-IM), make spinal circuits respond to those weak signals.
Brain-controlled timing
In ARC-BCI, a brain implant decodes the intent to move and triggers the matching stimulation, a digital bridge across the injury.
Papers & demos
- May 2023paperWalking naturally after spinal cord injury using a brain-spine interface (Nature) (opens nature.com)A paralyzed man walked naturally again when a brain implant was linked to spinal stimulation.
Update log
Fri 17 Oct 2025
- Major: RegulatorTest
Thu 19 Dec 2024
- Major: PressRegulatory
Mon 20 May 2024
- Major: PaperTest
Mon 6 Nov 2023
- Minor: PaperResearch
Wed 24 May 2023
- Major: PaperResearch
Wed 9 Nov 2022
- Minor: PaperResearch
Wed 31 Oct 2018
- Major: PaperResearch
About ONWARD Medical
ONWARD Medical
Spinal cord stimulation, brain-spine link
Dutch-Swiss company selling spinal cord stimulation to restore movement after spinal injury, based on work by Grégoire Courtine and Jocelyne Bloch. Its skin-electrode ARC-EX was FDA-authorized in Dec 2024; its implant is paired with a brain implant in a brain-spine link.
- Founded
- 201412 yrs
- Headquarters
- NetherlandsSwitzerland
- Status
- Public
- Listed
- ONWDEuronext
- Valuation
- public
- Works in
- NeurotechStimulation therapies
- Coverage
- 1 program · 7 updateslatest 17 Oct 2025checked 25 Sep
- People
- Dave MarverCEO

